
Gentem is a healthcare technology company that simplifies the reimbursement process for medical practices through its AI-powered revenue cycle management platform. Founded in 2019 by a physician and a former software engineer, Gentem aims to revive private healthcare practices by addressing the challenges of declining insurance reimbursements and rising operational costs. Their platform automates billing tasks, minimizes insurance denials, and provides detailed financial insights, helping practices increase revenue and improve cash flow. With a focus on behavioral health, TMS practices, and digital health companies, Gentem is positioned to transform the medical billing landscape and support the financial viability of healthcare providers.

Gentem is a healthcare technology company that simplifies the reimbursement process for medical practices through its AI-powered revenue cycle management platform. Founded in 2019 by a physician and a former software engineer, Gentem aims to revive private healthcare practices by addressing the challenges of declining insurance reimbursements and rising operational costs. Their platform automates billing tasks, minimizes insurance denials, and provides detailed financial insights, helping practices increase revenue and improve cash flow. With a focus on behavioral health, TMS practices, and digital health companies, Gentem is positioned to transform the medical billing landscape and support the financial viability of healthcare providers.
Founded: May 2019
Headquarters: San Francisco, California, United States
Product: AI-powered revenue cycle management / medical billing platform
Focus markets: Behavioral health, TMS practices, digital health companies
Total funding (reported): USD 13,700,000
Medical reimbursement and revenue cycle management for clinical practices
2019
Healthcare technology / Health fintech / Insurtech
Series A announced Feb 9, 2021; participants included Susa Ventures, Social Starts, Rocketship.vc, CoFound Partners, 500 Global.
“Led by Vulcan Capital with participation from specialist early-stage investors (e.g., Susa Ventures, 500 Global)”